COMPARISON OF 3 HIGH-AFFINITY SPECT RADIOTRACERS FOR THE DOPAMINE-D-2 RECEPTOR

被引:22
作者
ALTIKRITI, MS
BALDWIN, RM
ZEAPONCE, Y
SYBIRSKA, E
ZOGHBI, SS
LARUELLE, M
MALISON, RT
KUNG, HF
KESSLER, RM
CHARNEY, DS
HOFFER, PB
INNIS, RB
机构
[1] YALE UNIV,VET ADM MED CTR,DEPT DIAGNOST RADIOL,W HAVEN,CT 06516
[2] UNIV PENN,PHILADELPHIA,PA 19104
[3] VANDERBILT UNIV,NASHVILLE,TN 37240
来源
NUCLEAR MEDICINE AND BIOLOGY | 1994年 / 21卷 / 02期
关键词
D O I
10.1016/0969-8051(94)90007-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The regional brain distribution and pharmacological specificity of three high affinity tracers for the dopamine (DA) D-2 receptor: [I-123]IBF, [I-123]epidepride, and [I-123]2'-ISP were assessed by SPECT imaging of non-human primates. The ratios of striatal-to-occipital activities at the time of peak striatal uptake were 2.2, 6.3 and 1.7, respectively. From the peak striatal activities, washout rates were 33, 4 and 16%/h for [I-123]IBF, [I-123]epidepride and [I-123]2'-ISP, respectively. The reversibility of the striatal uptake of all three agents was demonstrated by the rapid displacement induced by the dopamine D, selective antipsychotic agent raclopride, which increased washout rates to 96, 58 and 43%/h. The administration of d-amphetamine, which induces release of dopamine, had no noticeable effect on [I-123]epidepride but increased the washout rate of [I-123]IBF. These results suggest that, among these three agents, [I-123]epidepride is the superior tracer for in vivo displacement studies because of its slow washout and high target-to-background ratios. However, for tracer kinetic modeling, [I-123]IBF may be the superior agent because of its early time of peak uptake and its higher target-to-background ratios than [I-123]2'-ISP.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 36 条
[1]  
ARNETT CD, 1986, J NUCL MED, V27, P1878
[2]   CHARACTERIZATION AND LOCALIZATION OF SEROTONIN RECEPTORS IN HUMAN-BRAIN POSTMORTEM [J].
BIEGON, A ;
KARGMAN, S ;
SNYDER, L ;
MCEWEN, BS .
BRAIN RESEARCH, 1986, 363 (01) :91-98
[3]  
BRUCKE T, 1991, J CEREBR BLOOD F MET, V11, P220
[4]   COMPARISON OF BOLUS AND INFUSION METHODS FOR RECEPTOR QUANTITATION - APPLICATION TO [F-18] CYCLOFOXY AND POSITRON EMISSION TOMOGRAPHY [J].
CARSON, RE ;
CHANNING, MA ;
BLASBERG, RG ;
DUNN, BB ;
COHEN, RM ;
RICE, KC ;
HERSCOVITCH, P .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (01) :24-42
[5]   PREPARATION OF [I-123] EPIDEPRIDE AND [I-125] EPIDEPRIDE - A DOPAMINE D-2 RECEPTOR ANTAGONIST RADIOLIGAND [J].
CLANTON, JA ;
DEPAULIS, T ;
SCHMIDT, DE ;
ANSARI, MS ;
MANNING, RG ;
BALDWIN, RM ;
KESSLER, RM .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1991, 29 (07) :745-751
[6]   LIGHT-DEPENDENT REGULATION OF DOPAMINE-RECEPTORS IN MAMMALIAN RETINA [J].
DUBOCOVICH, ML ;
LUCAS, RC ;
TAKAHASHI, JS .
BRAIN RESEARCH, 1985, 335 (02) :321-325
[7]   SUBSTITUTED BENZAMIDES AS LIGANDS FOR VISUALIZATION OF DOPAMINE RECEPTOR-BINDING IN THE HUMAN-BRAIN BY POSITRON EMISSION TOMOGRAPHY [J].
FARDE, L ;
EHRIN, E ;
ERIKSSON, L ;
GREITZ, T ;
HALL, H ;
HEDSTROM, CG ;
LITTON, JE ;
SEDVALL, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) :3863-3867
[8]  
FREY KA, 1985, J NEUROSCI, V5, P421
[9]   THE DOPAMINE NEUROLEPTIC RECEPTOR [J].
GRIGORIADIS, D ;
SEEMAN, P .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :108-113
[10]   AMPHETAMINE-STIMULATED DOPAMINE RELEASE COMPETES INVIVO FOR [I-123] IBZM BINDING TO THE D2-RECEPTOR IN NONHUMAN-PRIMATES [J].
INNIS, RB ;
MALISON, RT ;
ALTIKRITI, M ;
HOFFER, PB ;
SYBIRSKA, EH ;
SEIBYL, JP ;
ZOGHBI, SS ;
BALDWIN, RM ;
LARUELLE, M ;
SMITH, EO ;
CHARNEY, DS ;
HENINGER, G ;
ELSWORTH, JD ;
ROTH, RH .
SYNAPSE, 1992, 10 (03) :177-184